Failure to reproduce key experiments retracts cancer study

A group of Chinese cancer researchers has retracted a paper in Medical Oncology after they discovered that “several key experiments” were not reproducible. The paper, “Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer,” was published in March. It found that suppressing the enzyme ATP citrate lyase could be … Continue reading Failure to reproduce key experiments retracts cancer study

Authors defend publishing clinical trial six times, even as they earn two more retractions

In August, we reported on a clinical trial on hundreds of hypertensive patients that was published six times. Now, copies published in Expert Opinion on Drug Safety and Journal of the American Society of Hypertension (JASH) have been retracted, making for a total of three retractions for the group of papers. The authors have defended the papers as being decidedly … Continue reading Authors defend publishing clinical trial six times, even as they earn two more retractions

Is less publishing linked to more plagiarism?

Countries that publish less science appear to “borrow” more language from others than other, more scientifically prolific countries, according to a new small study. Using a novel approach of comparing a country’s total citations against its total published papers (CPP), the authors categorized 80 retractions from journals in general and internal medicine. This is a … Continue reading Is less publishing linked to more plagiarism?

Weekend reads: FDA nominee authorship questions; low economics replication rates

The week at Retraction Watch featured a mysterious retraction from PLOS ONE, and a thoughtful piece by a scientist we’ve covered frequently on where we went wrong in that coverage. Here’s what was happening elsewhere:

Journal bans authors of duplicated asthma paper

A common ailment known as duplication has taken down a paper about a common fungus and asthma. Aspergillus spores are often ubiquitous yet harmless, but can irritate people whose lungs aren’t in top working order. Duplication, on the other hand, is more universally deadly. The editors of The Pan African Medical Journal told us that, in addition to the retraction, there … Continue reading Journal bans authors of duplicated asthma paper

Mystery: PLOS One seeks investigation after publishing two papers with “substantial overlap”

PLOS One has retracted one of two cancer papers with “substantial overlap” that were reviewed simultaneously by different editors. This one’s a bit of a mystery — neither of the papers share an author, and no authors share institutions. Once the editors discovered the overlap, they contacted the authors. One group of authors provided the requested … Continue reading Mystery: PLOS One seeks investigation after publishing two papers with “substantial overlap”

Investigation ends in 6th retraction for Voinnet

A sixth paper co-authored by plant researcher Olivier Voinnet has been retracted by PLOS Pathogens “following an investigation into concerns.” The investigation found “several band duplications” in one figure provided by fifth author, Patrice Dunoyer, who took it from “the Master thesis of a former student working under his supervision, without the prior consultation or consent … Continue reading Investigation ends in 6th retraction for Voinnet

Publisher bans authors for apparent plagiarism

Three authors have been banned from journals published by IGM Publication, including the Journal of Medical Science and Clinical Research. The ban — a relatively infrequent occurrence in publishing — comes after the publisher removed a 2014 article that seems to have merely changed the title and authors of a 2013 article  from another journal. When … Continue reading Publisher bans authors for apparent plagiarism

Can you spot the signs of retraction? Just count the errors, says a new study

Clinical studies that eventually get retracted are originally published with significantly more errors than non-retracted trials from the same journal, according to a new study in BMJ. The authors actually called the errors “discrepancies” — for example, mathematical mistakes such as incorrect percentages of patients in a subgroup, contradictory results, or statistical errors. The study doesn’t predict … Continue reading Can you spot the signs of retraction? Just count the errors, says a new study

Skin study retracted twice in triple publication rub

The Indian Journal of Dermatology has retracted a paper on the potential genetic markers of psoriasis that had already been retracted once for redundant publication. The journal is chalking it up to an “administrative error” that caused it to publish a paper that had already appeared in two other outlets. According to one of the … Continue reading Skin study retracted twice in triple publication rub